ACAD vs BIIB: Which Stock is Better?
Side-by-side comparison of Acadia Pharmaceuticals Inc and Biogen Inc in 2026
ACAD
Acadia Pharmaceuticals Inc
$22.16
BIIB
Biogen Inc
$184.87
Key Metrics Comparison
| Metric | ACAD | BIIB | Winner |
|---|---|---|---|
| Market Cap | $3.78B | $27.13B | BIIB |
| P/E Ratio | 9.76 | 21.42 | ACAD |
| EPS (TTM) | $2.27 | $8.63 | BIIB |
| Revenue Growth | 0.1% | -0.1% | ACAD |
| Gross Margin | 61.0% | 78.9% | BIIB |
Analyze ACAD
Full quant analysis
Analyze BIIB
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ACAD or BIIB a better investment?
Comparing ACAD and BIIB: Acadia Pharmaceuticals Inc has a market cap of $3.78B while Biogen Inc has $27.13B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ACAD and BIIB?
ACAD (Acadia Pharmaceuticals Inc) and BIIB (Biogen Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ACAD or BIIB?
Based on P/E ratios, ACAD trades at a lower multiple (9.8x vs 21.4x).
Which is growing faster: ACAD or BIIB?
ACAD has higher revenue growth at 0.1% vs -0.1% for BIIB.
Which company is more profitable: ACAD or BIIB?
Biogen Inc (BIIB) has higher gross margins at 78.9% compared to 61.0% for ACAD.
Which is the larger company: ACAD or BIIB?
Biogen Inc (BIIB) is larger with a market cap of $27.13B compared to $3.78B for ACAD.
Should I buy ACAD or BIIB in 2026?
Both ACAD and BIIB have investment merit. ACAD trades at $22.16 while BIIB trades at $184.87. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ACAD and BIIB stock?
Key differences: Market Cap ($3.78B vs $27.13B), P/E Ratio (9.8x vs 21.4x), Revenue Growth (0.1% vs -0.1%), Gross Margin (61.0% vs 78.9%).